Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients

NCT05277792 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT05277792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 8, 2022
Completion date
June 8, 2024
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood concentration of tacrolimus metabolites